It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Amgen: "I like Amgen, it's one of the cheapest of the biotechs. I have cooled a tad to the biotechs because of this political situation going on where everybody hates them. I'm not hating on Amgen."
LPL Financial: "I've got to look into them again. You know, when I see that 5 percent yield on a company that is a technology company I do get a little bit concerned. Let me do some homework."
Celldex Therapeutics: "Oh man, they have taken this one to the woodshed. It's really incredible. If you want to like a speculative stock this is probably a good one to get started right here. Holy cow they have killed Celldex."
Read more from Mad Money with Jim Cramer
Omega Healthcare Investors: "I am concerned about the healthcare real estate investment trusts, they have been breaking down. I need more information on when Deb Cafaro, CEO of Ventas, will come on. I was just speaking with a healthcare real estate investment trust specialist who said to be careful of healthcare trusts. I have to be careful of Omega."
Nordic American Tanker: "The stock dropped too much after the quarter, which was not a bad quarter. It has a nice high yield of 13 percent ... but I have to tell you in the end, man this is a wild rider. But I do think that the yield is good because there is a demand for his tankers."
Tesoro: "We are not recommending any refinery stocks. Period. End of story. I don't like the margins."
Fitbit: "I was right Fitbit, I told you to get in, to get out, and then told you to get back in again — and I have been dead wrong. But I think when Fitbit reports, it will be a good quarter and James Park [CEO] will not let us down."